We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

62 hedge funds and large institutions have $115M invested in Filana Therapeutics in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more call options, than puts

Call options by funds: $447K | Put options by funds: $115K

72% more capital invested

Capital invested by funds: $67.2M → $115M (+$48.2M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

2% more funds holding

Funds holding: 61 → 62 (+1)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

0% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 18

Holders
62
Holders Change
+1
Holders Change %
+1.64%
% of All Funds
1.8%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
17
Increased
18
Reduced
18
Closed
16
Calls
$447K
Puts
$115K
Net Calls
+$332K
Net Calls Change
+$282K

Top Buyers

Rank Fund Capital Flow
1
SC
Sophrosyne Capital
New York
+$3.22M
2
First Eagle Investment Management
First Eagle Investment Management
New York
+$1.88M
3
ICMC
Intrepid Capital Management (Connecticut)
Connecticut
+$1.74M
4
BC
Broadfin Capital
New York
+$872K
5
BIT
BlackRock Institutional Trust
California
+$803K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$6.41M
2
BFA
BlackRock Fund Advisors
California
-$1.87M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.59M
4
Goldman Sachs
Goldman Sachs
New York
-$499K
5
GPP
Great Point Partners
Connecticut
-$429K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCA
51
SAC Capital Advisors
Connecticut
$56K +$43.6K +1,642 New
NES
52
New England Securities
New York
$6K – – –
AllianceBernstein
53
AllianceBernstein
Tennessee
$3K – – –
FNYS
54
First New York Securities
New York
$3K +$2.65K +100 New
TRCT
55
Tower Research Capital (TRC)
New York
$3K +$2.71K +102 New
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$2.86K +$2.23K +84 New
TCOV
57
Trust Company of Vermont
Vermont
$2K – – –
Citigroup
58
Citigroup
New York
$1K -$32.5K -1,225 -99%
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
$1K +$53 +2 +5%
GC
60
Globeflex Capital
California
$1K +$1.3K +49 New
Manulife (Manufacturers Life Insurance)
61
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$9 +$1.62K +61 +30%
BI
62
BVF Inc
California
– -$6.41M -336,761 Closed
Goldman Sachs
63
Goldman Sachs
New York
– -$499K -26,196 Closed
WFM
64
Wilmington Funds Management
Delaware
– -$142K -7,434 Closed
BG
65
BlackRock Group
United Kingdom
– -$119K -6,248 Closed
ACMI
66
Amida Capital Management II
New York
– -$103K -5,429 Closed
HK
67
Horizon Kinetics
New York
– -$103K -5,429 Closed
Public Employees Retirement Association of Colorado
68
Public Employees Retirement Association of Colorado
Colorado
– -$92K -4,843 Closed
ProShare Advisors
69
ProShare Advisors
Maryland
– -$43K -2,280 Closed
RCM
70
Rotella Capital Management
Washington
– -$30K -1,556 Closed
Group One Trading
71
Group One Trading
Illinois
– -$41.3K -1,555 Closed
BJ
72
BlackRock Japan
Japan
– -$19K -1,015 Closed
LTFS
73
Ladenburg Thalmann Financial Services
Florida
– -$5K -286 Closed
Creative Planning
74
Creative Planning
Kansas
– -$3K -171 Closed
Barclays
75
Barclays
United Kingdom
– -$2K -135 Closed
1 2
3
4

FLNA Hedge Fund Activity: Q4 2013 in Review

62 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2013, worth a combined $115M — up 72% from $67.2M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new FLNA positions and 16 closed out — a net gain of 1 holder — while 18 added to existing stakes and 18 trimmed.

The largest buyer was Sophrosyne Capital, adding an estimated $3.22M. The largest seller was BVF Inc, exiting entirely with an estimated $6.41M sold.

  • 62 institutional investors held Filana Therapeutics (FLNA) as of Q4 2013, up from 61 in Q3 2013.
  • Funds reported $115M of Filana Therapeutics stock for Q4 2013, up 72% quarter-over-quarter.
  • 17 funds opened new Filana Therapeutics positions in Q4 2013 and 16 closed out, a net change of +1 holder.
  • The largest Filana Therapeutics buyer in Q4 2013 was Sophrosyne Capital, an estimated $3.22M added.
  • The largest Filana Therapeutics seller in Q4 2013 was BVF Inc, an estimated $6.41M sold.

Based on aggregated 13F filings for Q4 2013.